Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;57(5):834-836.
doi: 10.1038/s41409-022-01618-5. Epub 2022 Feb 24.

Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study

Anna Candoni  1 , Davide Lazzarotto  2 , Alessandro Rambaldi  3 , Maria Vittoria Dubbini  2 , Paola Bresciani  4 , Alessandro Busca  5 , William Arcese  6 , Anna Paola Iori  7 , Roberto Sorasio  8 , Giuseppe Irrera  9 , Renato Fanin  2 , Fabio Ciceri  10 , Francesca Bonifazi  11 ; GITMO
Affiliations

Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study

Anna Candoni et al. Bone Marrow Transplant. 2022 May.
No abstract available

PubMed Disclaimer

References

    1. Hirschbühl K, Labopin M, Houhou M, Gabellier L, Labussière-Wallet H, Lioure B, et al. Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transpl. 2021;56:1190–9. https://doi.org/10.1038/s41409-020-01173-x - DOI
    1. Giebel S, Czyz A, Ottmann O, Baron F, Brissot E, Ciceri F, et al. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer 2016;122:2941–51. - DOI
    1. Brissot E, Labopin M, Beckers MM, Socié G, Rambaldi A, Volin L, et al. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia. Haematologica 2015;100:392–9. - DOI
    1. Warraich Z, Tenneti P, Thai T, Hubben A, Amin H, McBrideet A, et al. Relapse prevention with tyrosine kinase inhibitors after allogeneic transplantation for philadelphia chromosome-positive acute lymphoblast leukemia: a systematic review. Biol Blood Marrow Transpl. 2020;26:e55–e64. - DOI
    1. Saini N, Marin D, Ledesma C, Delgado R, Rondon G, Popat UR, et al. Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL. Blood. 2020;136:1786–9. - DOI

Publication types

MeSH terms

Substances

LinkOut - more resources